Evidence map›Paper›PMID 36551841›Full record

ArticleBiomedicines2022

Growth Arrest of Alveolar Cells in Response to Cytokines from Spike S1-Activated Macrophages: Role of IFN-γ.

Amelia Barilli, Rossana Visigalli, Francesca Ferrari, Giulia Recchia Luciani, Maurizio Soli, Valeria Dall'Asta, Bianca Maria Rotoli

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Amelia BarilliLaboratory of General Pathology, Department of Medicine and Surgery, University of Parma, 43125 Parma, Italy.ORCID 0000-0002-2256-0530
Rossana VisigalliLaboratory of General Pathology, Department of Medicine and Surgery, University of Parma, 43125 Parma, Italy.
Francesca FerrariLaboratory of General Pathology, Department of Medicine and Surgery, University of Parma, 43125 Parma, Italy.
Giulia Recchia LucianiLaboratory of General Pathology, Department of Medicine and Surgery, University of Parma, 43125 Parma, Italy.
Maurizio SoliImmunohematology and Transfusion Medicine, University Hospital of Parma, 43125 Parma, Italy.
Valeria Dall'AstaLaboratory of General Pathology, Department of Medicine and Surgery, University of Parma, 43125 Parma, Italy.ORCID 0000-0001-8540-0916
Bianca Maria RotoliLaboratory of General Pathology, Department of Medicine and Surgery, University of Parma, 43125 Parma, Italy.
University of Parma · IT

Funding

Ministero dell'Istruzione, dell'Università e della Ricerca, Italy PRIN, Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale (Prot. 2017R5ZE2C)
6 · The paper itself

Abstract

Acute respiratory distress syndrome (ARDS) is characterized by severe hypoxemia and high-permeability pulmonary edema. A hallmark of the disease is the presence of lung inflammation with features of diffuse alveolar damage. The molecular pathogenetic mechanisms of COVID-19-associated ARDS (CARDS), secondary to SARS-CoV-2 infection, are still not fully understood. Here, we investigate the effects of a cytokine-enriched conditioned medium from Spike S1-activated macrophage on alveolar epithelial A549 cells in terms of cell proliferation, induction of autophagy, and expression of genes related to protein degradation. The protective effect of baricitinib, employed as an inhibitor of JAK-STAT, has been also tested. The results obtained indicate that A549 exhibits profound changes in cell morphology associated to a proliferative arrest in the G0/G1 phase. Other alterations occur, such as a blockade of protein synthesis and the activation of autophagy, along with an increase of the intracellular amino acids content, which is likely ascribable to the activation of protein degradation. These changes correlate to the induction of IFN-regulatory factor 1 (IRF-1) due to an increased secretion of IFN-γ in the conditioned medium from S1-activated macrophages. The addition of baricitinib prevents the observed effects. In conclusion, our findings suggest that the IFN-γ-IRF-1 signaling pathway may play a role in the alveolar epithelial damage observed in COVID-19-related ARDS.

Indexed as

alveolar epithelial damageautophagybaricitinibhuman macrophagesIFN-γproliferative arrest

Identifiers

PMID36551841
PMCPMC9775973
OpenAlexW4311050764

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.